Business
information report
1. Summary Information
|
|
|
Country |
|
|
Company Name |
CELON
LABORATORIES LIMITED |
Principal Name 1 |
Mr. Venkata Ravindra Koganti |
|
Status |
Satisfactory |
Principal Name 2 |
Mr. Vimal Kumar Kavuru |
|
|
|
Registration # |
01-036097 |
|
Street Address |
Plot No.2, Aleap Industrial Estate, Gajularamaram, |
||
|
Established Date |
23.01.2001 |
SIC Code |
-- |
|
Telephone# |
91-40-23893683 / 23386041 |
Business Style 1 |
Development |
|
Fax # |
91-40-23893693 |
Business Style 2 |
Marketing |
|
Homepage |
Product Name 1 |
Injectable Pharmaceutical Products |
|
|
# of employees |
30 [Approximately] |
Product Name 2 |
-- |
|
Paid up capital |
Rs.
683,094,000/- |
Product Name 3 |
-- |
|
Shareholders |
Directors or relatives of directors
(74.55%) Other top fifty shareholders (25.45%) |
Banking |
ICICI Bank Limited |
|
Public Limited Corp. |
No |
Business Period |
11 Years |
|
IPO |
No |
International Ins. |
- |
|
Public |
No |
Rating |
Ba (45) |
|
Related
Company |
|||
|
Relation
|
Country
|
Company
Name |
CEO |
|
Sister Concern |
|
Celon Life Sciences Limited |
-- |
|
Note |
- |
||
2. Summary
Financial Statement
|
Balance Sheet as of |
31.03.2011 |
(Unit: Indian Rs.) |
|
|
Assets |
Liabilities |
||
|
Current Assets |
717,616,000 |
Current Liabilities |
139,423,000 |
|
Inventories |
260,347,000 |
Long-term Liabilities |
229,924,000 |
|
Fixed Assets |
209,254,000 |
Other Liabilities |
79,881,000 |
|
Deferred Assets |
000 |
Total Liabilities |
449,228,000 |
|
Invest& other Assets |
78,061,000 |
Retained Earnings |
107,506,000 |
|
|
|
Net Worth |
790,600,000 |
|
Total Assets |
1,265,278,000 |
Total Liab. & Equity |
1,265,278,000 |
|
Total Assets (Previous Year) |
509,395,000 |
|
|
|
P/L Statement as of |
31.03.2011 |
(Unit: Indian Rs.) |
|
|
Sales |
1016,612,000 |
Net Profit |
103,488,000 |
|
Sales(Previous yr) |
519,261,000 |
Net Profit(Prev.yr) |
84,739,000 |
|
Report Date : |
22.05.2012 |
IDENTIFICATION DETAILS
|
Name : |
CELON LABORATORIES LIMITED (w.e.f. 05.06.2007) |
|
|
|
|
Formerly Known
As : |
MEDVIN LABS PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
Plot No. 2, Aleap Industrial Estate, Gajularamaram, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as
on) : |
31.03.2011 |
|
|
|
|
Date of
Incorporation : |
23.01.2001 |
|
|
|
|
Com. Reg. No.: |
01-036097 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
Rs. 683.094
Millions |
|
|
|
|
CIN No.: [Company Identification
No.] |
U24232AP2001PLC036097 |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
HYDG01843C |
|
|
|
|
PAN No.: [Permanent Account No.] |
AACCG1654P |
|
|
|
|
Legal Form : |
A Closely Held Public Limited Liability Company |
|
|
|
|
Line of Business
: |
Development and Marketing of Injectable Pharmaceutical
Products. |
|
|
|
|
No. of Employees
: |
30 [Approximately] |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba (45) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 3100000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Usually Correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is an established company having satisfactory track. Trade relations
are reported as fair. Business is active. Payments are reported to be usually
correct and as per commitments. The company can be considered normal for business dealings at usual
trade terms and conditions. |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
|
A1 |
A1 |
|
|
|
|
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
LOCATIONS
|
Registered Office /Factory : |
Plot No. 2, Aleap Industrial Estate, Gajularamaram, |
|
Tel. No.: |
91-40-23893683 / 23386041 |
|
Fax No.: |
91-40-23893693 |
|
E-Mail : |
celonlife@gmail.com |
|
Website : |
|
|
|
|
|
Corporate Office : |
Plot No. 16, Achutha Co-op-Housing, Society, Road No. 10, Banjara
Hills, Hyderabad-500034, |
|
Tel. No.: |
91-40-23386040/ 40303838 |
|
Fax No.: |
91-40-23386041/ 40303939 |
|
E-Mail : |
asia@celonlabs.com (Asia
Pacific) latam@celonlabs.com ( africa@celonlabs.com ( cis@celonlabs.com (CIS) crm@celonlabs.com (Contract Research
Manufacturing) india@celonlabs.com |
|
|
|
|
Sales Office : |
405, Monte Rossa, 90 feet Road, Opposite
Ganesh Temple, Pant Nagar, Ghatkopar [East], Mumbai – 400075, Maharashtra,
India |
DIRECTORS
As on 16.07.2011
|
Name : |
Mr. Venkata Ravindra Koganti |
|
Designation : |
Managing Director |
|
Address : |
Plot No. 57, Flat No. 102, Shalivahana Nagar, |
|
Date of Birth/Age : |
20.08.1968 |
|
Date of Appointment : |
29.03.2007 |
|
DIN No.: |
00016266 |
Other Directorship :
|
S.No. |
CIN |
Name
of the Company |
Current
designation of the director |
Date
of appointment at current designation |
Original
date of appointment |
Date
of cessation |
Company
Status |
Defaulting
status |
|
1 |
U24230AP2005PTC045812 |
CREDENCE
ORGANICS PRIVATE LIMITED |
Director |
04-05-06 |
04-05-06 |
26-08-09 |
Active |
NO |
|
2 |
U24239AP2006PLC049375 |
CELON LIFE
SCIENCES LIMITED |
Director |
29-03-07 |
29-03-07 |
- |
Active |
NO |
|
3 |
U24232AP2001PLC036097 |
CELON
LABORATORIES LIMITED |
Managing
director |
03-08-11 |
29-03-07 |
- |
Active |
NO |
|
4 |
U24299AP2003PLC042283 |
DNA BIOTEC
LIMITED |
Additional
director |
01-10-07 |
01-10-07 |
01-10-09 |
Active |
NO |
|
5 |
U24239AP2005PTC046286 |
CELON ORGANICS
PRIVATE LIMITED |
Director |
26-02-08 |
26-02-08 |
31-07-11 |
Active |
NO |
|
6 |
U51909AP2008PLC061515 |
IN-TECH
INDUSTRIES LIMITED |
Director |
31-08-11 |
22-10-08 |
- |
Active |
NO |
|
7 |
U72200AP2009PTC062849 |
EXCELON SOFTWARE
SOLUTIONS PRIVATE LIMITED |
Director |
23-02-09 |
23-02-09 |
30-03-10 |
Active |
NO |
|
8 |
U74999AP2008PTC058673 |
KONDAPALLY
ENVIROTECH PRIVATE LIMITED |
Director |
30-03-09 |
30-03-09 |
- |
Active |
NO |
|
9 |
U24232AP2009PTC063678 |
MEDIGENE PHARMA
PRIVATE LIMITED |
Director |
15-05-09 |
15-05-09 |
31-03-10 |
Active |
NO |
|
10 |
U24232AP2009PTC063823 |
MEDIARK PHARMA
PRIVATE LIMITED |
Director |
29-05-09 |
29-05-09 |
31-03-10 |
Active |
NO |
|
11 |
U24231AP2009PTC065376 |
CLONZ BIOTECH
PRIVATE LIMITED |
Additional
director |
22-06-10 |
22-06-10 |
09-07-10 |
Active |
NO |
|
12 |
U24239AP2002PLC038581 |
SWYZER
LABORATORIES LIMITED |
Director |
19-09-11 |
06-08-11 |
- |
Active |
NO |
|
Name : |
Mr. Vimal Kumar Kavuru |
|
Designation : |
Director |
|
Address : |
263-16, |
|
Date of Birth/Age : |
08.10.1968 |
|
Date of Appointment : |
01.12.2007 |
|
DIN : |
00502935 |
Other Directorship :
|
S. No. |
CIN |
Name
of the Company |
Current
designation of the director |
Date
of appointment at current designation |
Original
date of appointment |
Date
of cessation |
Company
Status |
Defaulting
status |
|
1 |
U24299AP2003PLC042283 |
DNA BIOTEC
LIMITED |
Additional
director |
01-10-07 |
01-10-07 |
01-10-09 |
Active |
NO |
|
2 |
U24239AP2006PLC049375 |
CELON LIFE
SCIENCES LIMITED |
Director |
12-11-07 |
12-11-07 |
- |
Active |
NO |
|
3 |
U24232AP2001PLC036097 |
CELON
LABORATORIES LIMITED |
Additional
director |
03-08-11 |
01-12-07 |
- |
Active |
NO |
|
4 |
U45209AP2008PTC057214 |
Z AXIS
INFRASTRUCTURE ( |
Director |
18-01-08 |
18-01-08 |
- |
Active |
NO |
|
5 |
U45209AP2008PTC057213 |
SYCAMORE
INFRASTRUCTURE PRIVATE LIMITED |
Director |
18-01-08 |
18-01-08 |
- |
Active |
NO |
|
6 |
U24239AP2005PTC046286 |
CELON ORGANICS
PRIVATE LIMITED |
Director |
10-05-08 |
10-05-08 |
31-07-11 |
Active |
NO |
|
7 |
U24297AP2010PTC067165 |
GENSOURCE PHARMA
SOLUTIONS PRIVATE LIMITED |
Director |
23-02-10 |
23-02-10 |
- |
Active |
NO |
|
Name : |
Mr. Vijay Kumar Vasireddy |
|
Designation : |
Director |
|
Address : |
83 West hill Road, Wood Cliff Lake, New Jersey - 076778339, |
|
Date of Birth/Age : |
09.09.1967 |
|
Date of Appointment : |
29.09.2010 |
|
DIN : |
03262782 |
Other Directorship :
|
S.No. |
CIN |
Name
of the Company |
Current
designation of the director |
Date
of appointment at current designation |
Original
date of appointment |
Company
Status |
Defaulting
status |
|
1 |
U24232AP2001PLC036097 |
CELON LABORATORIES
LIMITED |
Director |
16-07-11 |
29-09-10 |
Active |
NO |
|
Name : |
Mr. Sandeep Singhal |
|
Designation : |
Director |
|
Address : |
C-76, Diamond District, |
|
Date of Birth/Age : |
31.12.1969 |
|
Date of Appointment : |
11.10.2010 |
|
DIN No.: |
00040491 |
Other Directorship :
|
S.No. |
CIN |
Name
of the Company |
Current
designation of the director |
Date
of appointment at current designation |
Original
date of appointment |
Date
of cessation |
Company
Status |
Defaulting
status |
|
1 |
U65999KA2000PTC033945 |
SEQUOIA CAPITAL
INDIA ADVISORS PRIVATE LIMITED |
Managing
director |
04-01-05 |
15-09-00 |
04-02-11 |
Active |
NO |
|
2 |
U85199KA2000PTC027913 |
STRAND LIFE SCIENCES
PRIVATE LIMITED |
Director |
26-04-04 |
26-04-04 |
22-09-10 |
Active |
NO |
|
3 |
U72200AP2001PTC036596 |
APPLABS
TECHNOLOGIES PRIVATE LIMITED |
Director |
04-02-05 |
04-02-05 |
13-09-11 |
Active |
NO |
|
4 |
U74899DL1995PTC065388 |
DR. LAL PATHLABS
PRIVATE LIMITED |
Nominee director |
25-05-05 |
25-05-05 |
- |
Active |
NO |
|
5 |
U72900MH1999PTC122970 |
NAZARA
TECHNOLOGIES PRIVATE LIMITED |
Nominee director |
07-10-05 |
07-10-05 |
- |
Active |
NO |
|
6 |
U72900MH2005PTC153248 |
PEOPLE INFOCOM PRIVATE
LIMITED |
Nominee director |
17-02-06 |
17-02-06 |
01-04-09 |
Active |
NO |
|
7 |
U72900MH2000PTC124485 |
PEOPLE
INTERACTIVE ( |
Nominee director |
22-02-06 |
22-02-06 |
- |
Active |
NO |
|
8 |
U71110DL2000PTC189230 |
CARZONRENT ( |
Nominee director |
28-10-06 |
28-10-06 |
- |
Active |
NO |
|
9 |
U74999AP2000PTC035826 |
GVK BIOSCIENCES
PRIVATE LIMITED |
Director |
08-11-07 |
08-11-07 |
15-04-11 |
Active |
NO |
|
10 |
U72200MH2006PTC160271 |
WHATS ON INDIA
MEDIA PRIVATE LIMITED |
Nominee director |
30-09-08 |
30-09-08 |
15-04-11 |
Active |
NO |
|
11 |
U74140MH1993PLC150054 |
JUST DIAL
LIMITED |
Nominee director |
18-09-09 |
18-06-09 |
- |
Active |
NO |
|
12 |
U74120MH2010PTC200998 |
JUST DIAL GLOBAL
PRIVATE LIMITED |
Director |
18-03-10 |
18-03-10 |
- |
Active |
NO |
|
13 |
U29301KA1999PTC025387 |
STOVE KRAFT
PRIVATE LIMITED |
Nominee director |
18-03-10 |
18-03-10 |
- |
Active |
NO |
|
14 |
L72200MH2000PLC125319 |
ECLERX SERVICES LIMITED |
Director |
16-09-10 |
30-04-10 |
- |
Active |
NO |
|
15 |
U24232AP2001PLC036097 |
CELON
LABORATORIES LIMITED |
Nominee director |
11-10-10 |
11-10-10 |
- |
Active |
NO |
|
16 |
U65191KA2011PTC057224 |
WESTBRIDGE
ADVISORS PRIVATE LIMITED |
Managing director |
24-02-11 |
23-02-11 |
- |
Active |
NO |
|
Name : |
Mr. Bhardwaj Thiruvenkata Venkatavaraghavan |
|
Designation : |
Additional Director |
|
Address : |
702, 7th Orchid Tower – A, 241 / 242, Bellasis Road, Mumbai
Central – 400008, Maharashtra, India |
|
Date of Birth/Age : |
26.06.1978 |
|
Date of Appointment : |
15.02.2011 |
|
DIN No.: |
02918495 |
Other Directorship :
|
S.No. |
CIN |
Name
of the Company |
Current
designation of the director |
Date
of appointment at current designation |
Original
date of appointment |
Date
of cessation |
Company
Status |
Defaulting
status |
|
1 |
U85110TN2007PTC064072 |
VASAN HEALTH
CARE PRIVATE LIMITED |
Nominee director |
18-12-09 |
18-12-09 |
- |
Active |
NO |
|
2 |
U74899DL1995PTC065388 |
DR. LAL PATHLABS
PRIVATE LIMITED |
Alternate
director |
02-08-10 |
02-08-10 |
25-04-11 |
Active |
NO |
|
3 |
U65999KA2000PTC033945 |
SEQUOIA CAPITAL
INDIA ADVISORS PRIVATE LIMITED |
Managing
director |
04-02-11 |
04-02-11 |
- |
Active |
NO |
|
4 |
U24232AP2001PLC036097 |
CELON
LABORATORIES LIMITED |
Director |
16-07-11 |
15-02-11 |
- |
Active |
NO |
|
5 |
U15311MP2009PTC021746 |
PRATAAP SNACKS
PRIVATE LIMITED |
Additional
director |
12-05-11 |
12-05-11 |
- |
Active |
NO |
|
6 |
U24239AP2002PLC038581 |
SWYZER
LABORATORIES LIMITED |
Director |
19-09-11 |
06-08-11 |
- |
Active |
NO |
|
7 |
L17110MH1987PLC044835 |
LOVABLE LINGERIE
LIMITED |
Nominee director |
22-09-11 |
22-09-11 |
- |
Active |
NO |
KEY EXECUTIVES
|
Name : |
Mr. Pameela Paruchuri |
|
Designation : |
Company Secretary |
|
Address : |
Plot No.206, S. P. Homes, Plot No.826 to 828, K P H B Phase II, |
|
Date of Birth/Age : |
13.10.1978 |
|
Date of Appointment : |
23.06.2011 |
|
Pan No.: |
AMFPP4589E |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
As on 16.07.2011
|
Names of Shareholders |
|
No. of Shares (Equity) |
|
Koganti Venkata Ravindra |
|
4194333 |
|
Kognati Geetha Sree |
|
1525000 |
|
Sama Ramchandra Reddy |
|
2135000 |
|
Sama Yashodha |
|
1525000 |
|
Vimal Kumar Kavuru |
|
2928000 |
|
Sudha Kavuru |
|
1525000 |
|
Vasireddy
Vijaykumar |
|
1952000 |
|
Vasireddy Hema Latha |
|
1525000 |
|
Vakati Narayan Reddy |
|
500000 |
|
Ganji Praveen Kumar Gupta |
|
500000 |
|
Sequoia Capital |
|
100 |
|
Total |
|
18309433 |
|
Names of Shareholders |
|
No. of Shares (Preference) |
|
Sequoia Capital |
|
49999250 |
|
Total |
|
49999250 |
(AS ON 17.09.2011)
|
Names of Allottee |
|
No. of Shares Allotted |
|
Bheemireddy Murali |
|
109662 |
|
Total |
|
109662 |
As on 16.07.2011
|
Category |
|
Percentage |
|
Directors or relatives of directors |
|
74.55 |
|
Other top fifty shareholders |
|
25.45 |
|
Total
|
|
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Development and Marketing of Injectable Pharmaceutical
Products. |
|
|
|
|
Products : |
·
Amifostine ·
Anastrozole ·
Bicalutamide ·
Capecitabine ·
Chlorambucil ·
Docetaxel ·
Gemcitabine HCl ·
Gefitinib ·
Imatinib Mesylate ·
Melphalan ·
Temozolomide ·
Ibandronic Acid ·
Zoledronic Acid |
|
|
|
|
Brand Names : |
·
Armilon ·
Cosalon ·
Bucelon ·
Xelocel ·
Celkeran ·
Leukocel ·
Celonib ·
Celofem ·
Alkacel ·
Temolon |
PRODUCTION STATUS (As ON: 31.03.2011)
|
Particulars |
Unit |
Licensed
Capacity |
Installed
Capacity |
Actual
Production |
|
Capsules |
Millions |
21.60 |
21.60 |
21.60 |
|
Tablets |
Millions |
72.00 |
72.00 |
72.00 |
|
Injections |
Millions |
3.60 |
3.16 |
3.16 |
GENERAL INFORMATION
|
No. of Employees : |
30 [Approximately] |
||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||
|
Bankers : |
·
ICICI Bank Limited, ·
State Bank of ·
State Bank of ·
State Bank of |
||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||
|
Facilities : |
|
||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
P Murali Mohana Rao Chartered Accountant |
|
Address : |
6-3-655/2/3, Somajiguda, |
|
Tel. No.: |
91-40-23326666 / 23312554 / 23393967 / 23321470 |
|
Fax No.: |
91-40-23392474 |
|
E-Mail : |
|
|
Web Site: |
|
|
|
|
|
Sister Concern / Subsidiary : |
· Celon Organics Private Limited (formerly know as Balasri Labs Private limited) · Celon Life Sciences Limited · In-tech Industries Private Limited (formerly know as In-tech Prints Private Limited) · KGS Constructions |
CAPITAL STRUCTURE
AS On 31.03.2011
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
20000000 |
Equity Shares |
Rs. 10/- each |
Rs .200.000 Millions |
|
70000000 |
Preference Shares |
Rs. 10/- each |
Rs. 700.000 Millions |
|
|
Total |
|
Rs. 900.000
millions |
Issued, Subscribed & Paid-up Capital:
|
No. of Shares |
Type |
Value |
Amount |
|
18309433 |
Equity Shares |
Rs. 10/- each |
Rs. 183.094
Millions |
|
49999250 |
Preference Shares |
Rs. 10/- each |
Rs. 499.993
Millions |
|
|
Share Premium |
|
Rs. 0.070
Millions |
|
|
Total |
|
Rs. 683.094 millions |
AFTER 16.07.2011
Authorised Capital : Rs. 900.000 Millions
Issued, Subscribed & Paid-up Capital: Rs. 884.183
Millions
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
683.094 |
65.000 |
43.321 |
|
|
2] Share Application Money |
0.000 |
0.000 |
4.550 |
|
|
3] Reserves & Surplus |
107.506 |
101.517 |
16.778 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
790.600 |
166.517 |
64.649 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
229.924 |
149.837 |
88.365 |
|
|
2] Unsecured Loans |
14.723 |
22.523 |
5.508 |
|
|
TOTAL BORROWING |
244.647 |
172.360 |
93.873 |
|
|
DEFERRED TAX LIABILITIES |
29.000 |
23.418 |
3.869 |
|
|
CREDITOR FOR CAPITAL GOODS |
10.727 |
24.286 |
17.092 |
|
|
|
|
|
|
|
|
TOTAL |
1074.974 |
386.581 |
179.483 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
209.254 |
140.660 |
119.217 |
|
|
Capital work-in-progress |
22.155 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
9.223 |
1.280 |
0.380 |
|
|
DEFERREX TAX ASSETS |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
260.347
|
144.499
|
42.009
|
|
|
Sundry Debtors |
310.315
|
165.380
|
53.195
|
|
|
Cash & Bank Balances |
206.389
|
7.630
|
7.905
|
|
|
Other Current Assets |
0.000
|
0.000
|
0.000
|
|
|
Loans & Advances |
200.912
|
12.643
|
5.758
|
|
Total
Current Assets |
977.963
|
330.152 |
108.867 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditor |
129.907
|
90.552
|
3.209
|
|
|
Other Current Liabilities |
9.516
|
3.405
|
42.769
|
|
|
Provisions |
50.881
|
28.858
|
5.980
|
|
Total
Current Liabilities |
190.304
|
122.815
|
51.958
|
|
|
Net Current Assets |
787.659
|
207.337
|
56.909
|
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
46.683 |
37.303 |
2.977 |
|
|
|
|
|
|
|
|
TOTAL |
1074.974 |
386.580 |
179.483 |
|
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
|
|
SALES |
|
|
|
|
|
|
|
Income |
1016.612 |
519.261 |
155.977 |
|
|
|
Other Income |
16.047 |
23.270 |
1.128 |
|
|
|
TOTAL (A) |
1032.659 |
542.531 |
157.105 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Raw Material Consumed |
654.175 |
375.293 |
89.932 |
|
|
|
Increase/(Decrease) in Finished Goods |
(39.306) |
(95.707) |
(23.807) |
|
|
|
Manufacturing Expenses |
33.042 |
58.034 |
24.013 |
|
|
|
Administrative, selling and Distribution Expenses |
143.082 |
36.221 |
28.094 |
|
|
|
Research and Development Expenditure |
53.379 |
6.624 |
4.850 |
|
|
|
Amortization Expenses Written off |
14.231 |
9.509 |
0.744 |
|
|
|
TOTAL (B) |
858.603 |
389.974 |
123.826 |
|
|
|
|
|
|
|
|
Less |
PROFIT
BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B) (C) |
174.056 |
152.557 |
33.279 |
|
|
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES (D) |
29.869 |
19.377 |
9.010 |
|
|
|
|
|
|
|
|
|
|
PROFIT
BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E) |
144.187 |
133.180 |
24.269 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION (F) |
8.849 |
7.547 |
3.599 |
|
|
|
|
|
|
|
|
|
|
PRIOR PERIOD
EXPENDITURE |
(0.881) |
0.000 |
0.038 |
|
|
|
|
|
|
|
|
|
|
PROFIT BEFORE
TAX |
136.219 |
125.633 |
20.632 |
|
|
|
|
|
|
|
|
|
Less |
TAX |
32.731 |
40.894 |
5.994 |
|
|
|
|
|
|
|
|
|
|
PROFIT AFTER TAX
|
103.488 |
84.739 |
14.638 |
|
|
|
|
|
|
|
|
|
Add |
PREVIOUS
YEARS’ BALANCE BROUGHT FORWARD |
101.516 |
16.777 |
2.139 |
|
|
|
|
|
|
|
|
|
|
BALANCE CARRIED
TO THE B/S |
205.004 |
101.516 |
16.777 |
|
|
|
|
|
|
|
|
|
|
EARNINGS IN
FOREIGN CURRENCY |
|
|
|
|
|
|
|
Foreign Exchange Inflow - Sales |
47.171 |
20.457 |
0.387 |
|
|
|
Foreign Exchange Earnings – Export Sales |
91.916 |
27.406 |
3.407 |
|
|
TOTAL EARNINGS |
139.087 |
47.863 |
3.794 |
|
|
|
|
|
|
|
|
|
|
Earnings Per
Share (Rs.) |
7.10 |
12.94 |
3.38 |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
PAT / Total Income |
(%) |
10.02
|
15.32
|
9.32
|
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
1340
|
24.19
|
13.23
|
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
34.09
|
26.68
|
9.04
|
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.17
|
0.75
|
0.32
|
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
0.59
|
1.77
|
2.26
|
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.24
|
2.69
|
2.09
|
LOCAL AGENCY FURTHER INFORMATION
|
Check list by info
Agents |
Available in Report (Yes/ No) |
|
Year of Establishment |
Yes |
|
Locality of the Firm |
Yes |
|
Constitution of the Firm |
Yes |
|
Premises details |
No |
|
Type of Business |
Yes |
|
Line of Business |
Yes |
|
Promoter’s Background |
Yes |
|
No. of Employees |
Yes |
|
Name of Person Contacted |
No |
|
Designation of Contact person |
No |
|
Turnover of Firm for last three years |
Yes |
|
Profitability for last three years |
Yes |
|
Reasons for variation <> 20% |
---------- |
|
Estimation for coming financial year |
No |
|
Capital in the business |
No |
|
Details of sister concerns |
Yes |
|
Major Suppliers |
No |
|
Major Customers |
No |
|
Payments Terms |
No |
|
Export/ Imports Details (If applicable) |
No |
|
Market Information |
----------- |
|
Litigations that the firm/ Promoters Involved in |
---------------- |
|
Banking details |
Yes |
|
Banking Facility Details |
Yes |
|
Conduct of the Banking Account |
--------------- |
|
Buyer visit details |
------------- |
|
Financials, if provided |
Yes |
|
Incorporation details is applicable |
Yes |
|
Last Accounts filed at ROC |
Yes |
|
Major Shareholders, if available |
Yes |
NOTE:
The Registered Office of the company has been
shifted from Flat No. 102, Lakshmi Residency, Shalivahana Nagar, Srinagar
Colony,
Fixed Assets:
· Land
· Building
· Leasehold Improvements
· Plant and Machinery
· Quality Control Equipments
· Air Conditioner
· Furniture and Fixtures
· Office Equipments
· Vehicles
· Electronic Data Processing Equipment
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction registered
against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling shareholders,
director, officer or employee of the company is a government official or a
family member or close business associate of a Government official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on Corporate
Governance to identify management and governance. These factors often have been
predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs. 54.68 |
|
|
1 |
Rs. 86.52 |
|
Euro |
1 |
Rs. 69.85 |
INFORMATION DETAILS
|
Report Prepared
by : |
ACH |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
5 |
|
PAID-UP CAPITAL |
1~10 |
5 |
|
OPERATING SCALE |
1~10 |
5 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
5 |
|
--PROFITABILIRY |
1~10 |
5 |
|
--LIQUIDITY |
1~10 |
5 |
|
--LEVERAGE |
1~10 |
5 |
|
--RESERVES |
1~10 |
5 |
|
--CREDIT LINES |
1~10 |
5 |
|
--MARGINS |
-5~5 |
--- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
Yes |
|
--LITIGATION |
YES/NO |
No |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
No |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
No |
|
--EXPORT ACTIVITIES |
YES/NO |
No |
|
--AFFILIATION |
YES/NO |
Yes |
|
--LISTED |
YES/NO |
No |
|
--OTHER MERIT FACTORS |
YES/NO |
Yes |
|
TOTAL |
|
45 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
- |
NB |
New Business |
- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.